The Patent Finder

Serenity Pharmaceuticals LLC

Also on record
Records under this name other than the patents Serenity Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Serenity Pharmaceuticals LLC

PatentTitleStatus Expires Confidence
US 9,539,302Safe Desmopressin Administration
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,090,190Safe Desmopressin Administration
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,568,927Methods and Compositions Comprising Desmopressin in Combination with a BETA-3-Adrenergic Receptor Agonist
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,286,033Methods and Compositions Comprising Desmopressin in Combination with an Alpha-Adrenergic Receptor Antagonist
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,925,232Methods and Compositions Comprising Desmopressin in Combination with a 5-Alpha Reductase Inhibitor
Formerly held
Lapsed on the fee record
Ended Mar 27, 2026 · High confidence
Lapsed on the fee recordEnded Mar 27, 2026High confidence
US 7,799,761Pharmaceutical Compositions Including Low Dosages of Desmopressin
Formerly held
Term ended
Term ended Sep 26, 2024 · Medium confidence
Term endedTerm ended Sep 26, 2024Medium confidence
US 7,405,203Pharmaceutical Compositions Including Low Dosages of Desmopressin
Formerly held
Term ended
Term ended May 6, 2023 · Medium confidence
Term endedTerm ended May 6, 2023Medium confidence
US 8,143,225Pharmaceutical Compositions Including Low Dosages of Desmopressin
Formerly held
Term ended
Ended no later than May 6, 2023 · Low confidence
Term endedEnded no later than May 6, 2023Low confidence
US 9,814,753Methods and Compositions Comprising Desmopressin in Combination Wtih a BETA-3-Adrenergic Receptor Agonist
Lapsed on the fee record
Ended Nov 14, 2021 · High confidence
Lapsed on the fee recordEnded Nov 14, 2021High confidence
US 7,579,321Pharmaceutical Compositions Including Low Dosages of Desmopressin
Lapsed on the fee record
Ended Aug 25, 2021 · Low confidence
Lapsed on the fee recordEnded Aug 25, 2021Low confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited